Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia

2012 ◽  
Vol 158 (2) ◽  
pp. 246-252 ◽  
Author(s):  
Masao Moroi ◽  
Akira Yamashina ◽  
Kazumasa Tsukamoto ◽  
Tsunehiko Nishimura
Author(s):  
Qais Radaideh ◽  
Nicolas W. Shammas ◽  
Ghassan E. Daher ◽  
Rayan Jo Rachwan

AbstractStable ischemic heart disease (SIHD) affects approximately 10 million Americans with 500,000 new cases diagnosed each year. Patients with SIHD are primarily managed in the outpatient setting with aggressive cardiovascular risk factor modification via medical therapy and lifestyle changes. Currently, this approach is considered as the mainstay of treatment. The recently published ISCHEMIA trial has established the noninferiority of medical therapy in comparison to coronary revascularization in patients with moderate to severe ischemia. Percutaneous coronary intervention is currently recommended for patients with significant left main disease, large ischemic myocardial burden, and patients with severe refractory angina despite maximal medical therapy.


Author(s):  
Christiane Wiefels ◽  
Fernanda Erthal ◽  
Robert A. deKemp ◽  
Aun Yeong Chong ◽  
Lisa M. Mielniczuk ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document